Piper Sandler Reiterates Overweight on OrthoPediatrics, Raises Price Target to $25

Benzinga · 1d ago
Piper Sandler analyst Matt O'Brien reiterates OrthoPediatrics (NASDAQ:KIDS) with a Overweight and raises the price target from $22 to $25.